Suzetrigine for breast diseases

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 11 Mar 2026: Trial registered, NCT07463430
  2. 14 Apr 2026: Trial started, NCT07463430

The trials

NCT07463430: Suzetrigine for Non-Mastectomy Breast Surgery

State
Under way
Phase
Phase 4
People
120 planned
Started
14 Apr 2026
Primary completion
27 Jun 2027
Arms
Experimental: Suzetrigine
Results
None posted
  1. 11 Mar 2026: Trial registered
  2. 14 Apr 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Journavx, Suz, Suzetrigine (Journavx), Suzetrigine (SUZ), Suzetrigine Group, oral suzetrigine.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.